Pharmacological Inhibition of Endogenous Hydrogen Sulfide Attenuates Breast Cancer Progression
Nazeer Hussain Khan(University of Illinois Chicago), Dongdong Wu(Henan University), Wenkang Wang(ZheJiang Institute For Food and Drug Control), Ebenezeri Erasto Ngowi(Henan University), Muhammad Shahid(National University of Malaysia), Muhammad Sarfraz(University of Lahore), Di Wang(Zhejiang University), Saadullah Khattak(Wenzhou Medical University), Chunyang Zhang(Chinese Academy of Sciences), Xin‐Ying Ji(Henan University)
Cited by 30
Related Papers
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
|Cell Death Discovery|2024|145
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
|Cell Death and Disease|2023|130
Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways
|Scientific Reports|2017|121
Intensive Care Unit-Acquired Weakness: A Review of Recent Progress With a Look Toward the Future
|Frontiers in Medicine|2020|117
Hydrogen Sulfide Biology and Its Role in Cancer
|Molecules|2022|110